Fig. 1

Patient selection flowchart for T2DM patients with CKD in the CITE study, illustrating the screening of 10,915 patients, diagnosis of 3,493 CKD cases, exclusion of 168 patients, and categorization based on eGFR (mL/min/1.73 m²) and UACR (mg/g) levels